Clinical Trials Browser

Phase 2 × Enrolling by invitation × Pancreatic Cancer Non-resectable × Clear all

NCT07386704 2026-02-04

Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer

Phase 2 Enrolling by invitation

Gastrointestinal

Pancreatic Cancer Non-resectable